loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.
.
novartis india appoints milan paleja as vice chairman and md
.
super bowl ticket prices have come down a bit, but are still at record
.
.
.
.
family slam health trust after pensioner's 'undignified' death
.